Investigators fault Lilly plant for manufacturing issues

Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, government agencies, Health, Human Health, legal, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today, lots of regulatory content! We talk about march-in rights and chastening TikTok influencers for their prescription drug #sponcon.

Read the rest…

Read Original Article: Investigators fault Lilly plant for manufacturing issues »

About The Author